chr4-89815772-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000345.4(SNCA):​c.306+6474C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.675 in 151,982 control chromosomes in the GnomAD database, including 35,070 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.67 ( 35070 hom., cov: 33)

Consequence

SNCA
NM_000345.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0500

Publications

1 publications found
Variant links:
Genes affected
SNCA (HGNC:11138): (synuclein alpha) Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Alternatively spliced transcripts encoding different isoforms have been identified for this gene. [provided by RefSeq, Feb 2016]
SNCA Gene-Disease associations (from GenCC):
  • autosomal dominant Parkinson disease 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • autosomal dominant Parkinson disease 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Lewy body dementia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hereditary late onset Parkinson disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • parkinsonian-pyramidal syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.724 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000345.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNCA
NM_000345.4
MANE Select
c.306+6474C>T
intron
N/ANP_000336.1P37840-1
SNCA
NM_001146054.2
c.306+6474C>T
intron
N/ANP_001139526.1P37840-1
SNCA
NM_001146055.2
c.306+6474C>T
intron
N/ANP_001139527.1P37840-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNCA
ENST00000394991.8
TSL:1 MANE Select
c.306+6474C>T
intron
N/AENSP00000378442.4P37840-1
SNCA
ENST00000394986.5
TSL:1
c.306+6474C>T
intron
N/AENSP00000378437.1P37840-1
SNCA
ENST00000394989.6
TSL:1
c.264+6474C>T
intron
N/AENSP00000378440.2P37840-3

Frequencies

GnomAD3 genomes
AF:
0.675
AC:
102468
AN:
151866
Hom.:
35047
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.622
Gnomad AMI
AF:
0.796
Gnomad AMR
AF:
0.598
Gnomad ASJ
AF:
0.601
Gnomad EAS
AF:
0.661
Gnomad SAS
AF:
0.501
Gnomad FIN
AF:
0.742
Gnomad MID
AF:
0.598
Gnomad NFE
AF:
0.730
Gnomad OTH
AF:
0.661
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.675
AC:
102535
AN:
151982
Hom.:
35070
Cov.:
33
AF XY:
0.670
AC XY:
49765
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.622
AC:
25804
AN:
41454
American (AMR)
AF:
0.597
AC:
9115
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.601
AC:
2088
AN:
3472
East Asian (EAS)
AF:
0.661
AC:
3410
AN:
5162
South Asian (SAS)
AF:
0.502
AC:
2420
AN:
4816
European-Finnish (FIN)
AF:
0.742
AC:
7829
AN:
10554
Middle Eastern (MID)
AF:
0.609
AC:
179
AN:
294
European-Non Finnish (NFE)
AF:
0.730
AC:
49577
AN:
67940
Other (OTH)
AF:
0.658
AC:
1389
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1681
3361
5042
6722
8403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.689
Hom.:
4756
Bravo
AF:
0.668
Asia WGS
AF:
0.571
AC:
1979
AN:
3466

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
1.4
DANN
Benign
0.68
PhyloP100
0.050
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1442145; hg19: chr4-90736923; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.